D
Verrica Pharmaceuticals Inc. VRCA
$5.16 -$0.07-1.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -48.60M -65.99M -76.58M -84.99M -86.93M
Total Depreciation and Amortization 1.00M 1.14M 1.27M 1.23M 1.10M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 9.52M 11.24M 12.36M 13.40M 20.53M
Change in Net Operating Assets -9.26M -48.00K 2.03M 10.99M -316.00K
Cash from Operations -47.34M -53.66M -60.93M -59.37M -65.62M
Capital Expenditure -16.00K -27.00K -27.00K -254.00K -303.00K
Sale of Property, Plant, and Equipment 8.00K 8.00K 8.00K -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -8.00K -19.00K -19.00K -254.00K -303.00K
Total Debt Issued -- -- -- 0.00 44.11M
Total Debt Repaid -8.80M -4.83M -924.00K -573.00K -356.00K
Issuance of Common Stock 39.64M 39.79M 39.79M 154.00K 154.00K
Repurchase of Common Stock -- -- -- -1.00K -1.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -18.00K -631.00K -1.14M -1.31M -1.19M
Cash from Financing 30.82M 34.33M 37.73M -1.73M 42.72M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -16.53M -19.34M -23.22M -61.35M -23.21M